Registration - Organization
Gilead Sciences Canada, Inc. / Kenneth Scott Spencer, Executive Director, Finance and Interim General Manager
Registration Information
Senior Officer Name: Kenneth Scott Spencer, Executive Director, Finance and Interim General Manager
Senior Officer Change History
Initial registration start date: 2012-05-10
Registration status: Active
Projected end date: No date provided
Registration number: 10590-1560
Associated Lobbying Activity Reports
Total number of Lobbying Activity Reports: 0
Lobbying Activity Reports - last 6 months: 0
Version 26 of 28 (2023-07-18 to 2024-01-29)
Version 26 of 28 (2023-07-18 to 2024-01-29)
Lobbying Information
Details Regarding the Identified Subject Matter |
||||||||||
| Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below: | No | |||||||||
|
||||||||||
BC Ministries/Provincial Entities
- Fraser Health Authority
- Health
- Interior Health Authority
- Member(s) of the BC Legislative Assembly
- Mental Health and Addictions
- Nisga'a Valley Health Authority
- Northern Health Authority
- Providence Health Care Society
- Provincial Health Services Authority
- Vancouver Coastal Health Authority
- Vancouver Island Health Authority
Organization Details
Senior Officer Name and Position during the Period of this Registration
Christophe GRIOLET, Vice President and General Manager
Organization Contact Information
Gilead Sciences Canada, Inc.
Address:
6711 Mississauga Road
Suite 600
Mississauga, ON L5N 2W3
Canada
Telephone number:
416-919-6379
Description of Activities
Gilead Sciences Canada, Inc. is the Canadian affiliate of Gilead Sciences Inc. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company has a focus within the HIV, hepatitis, antiviral agents for pandemic response for COVID-19, inflammatory diseases, oncology and respiratory therapeutic areas.
Gifts or benefits provided by the organization
| Name | Gift or Benefit Description | Circumstance | Date Promised | Value Promised | Date Given | Value Given |
|---|---|---|---|---|---|---|
| No Records | ||||||
Contributors to the Lobbying Activity
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.
Government Funding in the Last 12 Months
No government funding was requested or received within the preceding 12 months.Coalition Members Information
Gilead Sciences Canada, Inc. is not a coalition member.
Affiliates with a Direct Interest in the Outcome
Gilead Sciences Canada, Inc. does not have any affiliates that could have a direct interest in the outcome of the lobbying activities
Other Persons or Organizations with Direct Interests
The activities of Gilead Sciences Canada, Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Lobbyists Details
| Lobbyist | Contributions | ||
|---|---|---|---|
|
Christophe GRIOLET Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
|
Katia Oteman Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
|
Robert Woolstencroft Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
- Date Modified: